IFM Investors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,630
| Closed | -$1.59M | – | 660 |
|
|
2024
Q4 | $1.59M | Sell |
8,630
-755
| -8% | -$139K | 0.02% | 540 |
|
|
2024
Q3 | $1.85M | Sell |
9,385
-275
| -3% | -$54.2K | 0.02% | 539 |
|
|
2024
Q2 | $2M | Buy |
9,660
+74
| +0.8% | +$15.3K | 0.02% | 522 |
|
|
2024
Q1 | $2.6M | Buy |
+9,586
| New | +$2.6M | 0.03% | 478 |
|
|
2023
Q4 | – | Sell |
-8,963
| Closed | -$1.76M | – | 586 |
|
|
2023
Q3 | $1.76M | Buy |
8,963
+797
| +10% | +$156K | 0.02% | 531 |
|
|
2023
Q2 | $1.72M | Buy |
8,166
+213
| +3% | +$44.8K | 0.02% | 530 |
|
|
2023
Q1 | $1.61M | Buy |
7,953
+34
| +0.4% | +$6.86K | 0.02% | 530 |
|
|
2022
Q4 | $1.73M | Sell |
7,919
-178
| -2% | -$38.8K | 0.03% | 503 |
|
|
2022
Q3 | $1.59M | Buy |
8,097
+519
| +7% | +$102K | 0.03% | 503 |
|
|
2022
Q2 | $1.62M | Hold |
7,578
| – | – | 0.03% | 506 |
|
|
2022
Q1 | $2.15M | Buy |
7,578
+1,310
| +21% | +$372K | 0.03% | 478 |
|
|
2021
Q4 | $2.36M | Hold |
6,268
| – | – | 0.04% | 409 |
|
|
2021
Q3 | $2.59M | Buy |
6,268
+35
| +0.6% | +$14.4K | 0.05% | 360 |
|
|
2021
Q2 | $2.31M | Buy |
+6,233
| New | +$2.31M | 0.05% | 417 |
|